| 引用本文: | 袁辉,衣琪昆,李士壮,梁家文,张雨婷,陈浩亮,阎雪莹.载小白菊内酯靶向脂质体的制备及体外抗肿瘤研究[J].药学研究,2024,43(11):1045-1052,1071[点击复制] |
|
| 摘要: |
| 目的 制备搭载cNGQ(环状多肽)的小白菊内酯脂质体(cNGQ-Lips@PTL)并进行处方优化以及体外抗肿瘤研究。方法 以包封率为指标,用Box-Behnken设计—效应面法优化处方,用透射电镜、激光粒度仪、动态透析法、可见分光光度法等检测cNGQ-Lips@PTL的形态、粒径、体外释药行为、血清稳定性和血液相容性;用荧光显微镜、CCK-8法、凋亡检测试剂盒和流式细胞术等检测脂质体的细胞相容性、cNGQ-Lips@PTL对非小细胞肺癌细胞的靶向效率和细胞毒性。结果 成功制备cNGQ-Lips@PTL,粒径均一,呈类球形态,平均粒径为128.3 nm,Zeta电位为-26.7 mV,包封率为74.89%,载药量12.08%。cNGQ-Lips@PTL在pH=5.5的PBS中,24 h累计释放量62.35%。细胞摄取实验中,cNGQ-Lips@PTL组荧光强度和摄取率明显高于PTL-Lips组以及游离组。在细胞毒性实验,cNGQ-Lips@PTL中PTL浓度为80 μmol·L-1时,孵育48 h后,A549细胞存活率为5.21%。在细胞凋亡实验中,cNGQ-Lips@PTL组98.74%的细胞处于凋亡晚期。结论 本研究制备的cNGQ-Lips@PTL具有较为明显的靶向作用以及较强的抑制非小细胞肺癌的效果,为后续开发具有靶向作用的纳米制剂提供了一种较有价值的参考。 |
| 关键词: 小白菊内酯 环状多肽cNGQ 靶向脂质体 处方优化 非小细胞肺癌 |
| DOI:10.13506/j.cnki.jpr.2024.11.002 |
| 基金项目:黑龙江省自然科学基金项目(No.LH2021H102);黑龙江省大学生创新创业训练计划项目(No.S202310228051);黑龙江中医药大学大学生科技创新项目(No.KZ2022-02) |
|
出版日期:2024-11-25
|
|
| Preparation and anti-tumor study of parthenolide targeting liposomes in vitro |
| YUAN Hui,YI Qikun,LI Shizhuang,LIANG Jiawen,ZHANG Yuting,CHEN Haoliang,YAN Xueying |
| (Heilongjiang University of Chinese Medicine, Harbin 150040, China) |
| Abstract: |
| Objective To prepare cNGQ (cyclic polypeptide) -loaded parthenolide liposomes (cNGQ-Lips@PTL), optimize the formulation and perform anti-tumor study in vitro.Methods Using encapsulation rate as index, Box-Behnken design-effect surface method was used to optimize the prescription. The morphology, particle size, in vitro drug release behavior, serum stability and blood compatibility of cNGQ-Lips@PTL were detected by transmission electron microscopy, laser particle size analyzer, dynamic dialysis and visible spectrophotometry. Fluorescence microscopy, cck-8 assay, apoptosis detection kit and flow cytometry were used to detect cell compatibility, cNGQ-Lips@PTL targeting efficiency and cytotoxicity of NSCLC cells. Results cNGQ-Lips@PTL was successfully prepared with uniform particle size and spheroid shape, the average particle size was 128.3 nm, the Zeta potential was -26.7 mV, the encapsulation rate was 74.89%, and the drug loading was 12.08%.cNGQ-Lips@PTL In PBS with pH=5.5, the cumulative release in 24 h was 62.35%.In the cell uptake experiment, the fluorescence intensity and uptake rate of cNGQ-Lips@PTL group were significantly higher than those of TL-Lips group and free group.In the cytotoxicity test, the PTL concentration in cNGQ-Lips@PTL was 80 μmol·L-1, and the survival rate of A549 cells was 5.21% after incubation for 48 h.In the apoptosis experiment, 98.74% of cells in cNGQ-Lips@PTL group were in the late stage of apoptosis.Conclusion The cNGQ-Lips@PTL prepared in this study has obvious targeting effect and strong inhibitory effect on non-small cell lung cancer, which provides a valuable reference for the subsequent development of nano preparations with targeting effect. |
| Key words: Parthenolide cNGQ Targeting liposome Prescription optimization NSCLC |